Dr. Huang joined Achillion in 2001 and currently serves as Senior Vice President and Head of Research. Dr. Huang began her tenure at Achillion as Director of Biology and has advanced through her outstanding contributions to the Company’s discovery efforts and innovations in building the portfolio. She is a pioneer in the discovery and development of the first oral factor D inhibitor, ACH-4471, as well as the next-generation compounds. Dr. Huang received her medical training at Shanghai Medical School, Fudan University, her Ph.D. at the University of New Mexico, and her postdoctoral training at the National Institutes of Health. She was a research fellow at National Cancer Institute and also head of antiviral research at Southern Research Institute prior to joining Achillion.